[1]
T. Barnett, “Glucagon-Like Peptide-1 Receptor Agonists in People With Human Immunodeficiency Virus: An Expanded Meta-Analysis of Metabolic Outcomes”, Cell Mol Med Res, vol. 3, no. 2, pp. 25–34, Jan. 2025, doi: 10.14740/cmmr114.